2018
DOI: 10.1111/jphp.12906
|View full text |Cite
|
Sign up to set email alerts
|

Copaiba oil enhances in vitro/in vivo cutaneous permeability and in vivo anti-inflammatory effect of celecoxib

Abstract: 25% C.O is a potential penetration enhancer for lipophilic drugs like Cxb that can improve cutaneous drug penetration and its anti-inflammatory activity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 57 publications
0
4
0
Order By: Relevance
“…Karpanen et al (2010), presented that the use of EO, which has antimicrobial activity, in a formulation increases the penetration of chlorhexidine as well as its antimicrobial activity. Similarly in another study adding 25% copaiba oil to the formulation increased both the penetration and antiinflammatory activity of celecoxib (Quiñones et al 2018).…”
Section: In Vitro Skin Permeation Studymentioning
confidence: 79%
“…Karpanen et al (2010), presented that the use of EO, which has antimicrobial activity, in a formulation increases the penetration of chlorhexidine as well as its antimicrobial activity. Similarly in another study adding 25% copaiba oil to the formulation increased both the penetration and antiinflammatory activity of celecoxib (Quiñones et al 2018).…”
Section: In Vitro Skin Permeation Studymentioning
confidence: 79%
“…The benefits of Chls in PDT treatment can be harnessed through emulsions containing oil drops (emulgels), which provide preferential means of PS monomerizing. In this process, copaiba oil (CO) offers advantages in skin treatment, due to its cell regeneration properties [23][24][25][26][27], as widely recognized in popular culture. CO from the Copaifera reticulata genus is rich in sesquiterpenes and diterpene compounds [28].…”
Section: Introductionmentioning
confidence: 99%
“…Despite the number of anti-inflammatory and analgesic drugs available in the market, the treatment schedules of these clinical conditions are complex and pose huge challenges to the health systems worldwide [24,25]. is scenario points out the urgent need for the development of effective analgesic and anti-inflammatory drugs [26][27][28].…”
Section: Introductionmentioning
confidence: 99%